글로벌 연구동향
핵의학
- 2021년 11월호
[PLoS One.] Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration
서울의대 / 이환희, 팽진철*
- 출처
- PLoS One.
- 등재일
- 2021 Sep 7
- 저널이슈번호
- 16(9):e0256727. doi: 10.1371/journal.pone.0256727. eCollection 2021.
- 내용
Abstract
Low-iodine diet (LID) is a crucial preparation for radioactive iodine (RAI) treatment or scan in thyroid cancer. The aim of this study is to analyze the influence of thyroid stimulating hormone (TSH) stimulation protocols and other clinical factors on LID adequacy. Thyroid cancer patients who underwent LID for RAI scan or treatment were retrospectively analyzed. Patients were guided to have LID for 2 weeks before RAI administration and urine iodine/creatinine ratio (UICR, μg/g Cr) was measured. TSH stimulation was conducted using either thyroid hormone withdrawal (THW) or recombinant human TSH (rhTSH) injection. Adequacy of LID was classified by UICR as 'excellent (< 50)', 'adequate (50-100)', 'inadequate (101-250)' and 'poor (> 250)'. A total of 1715 UICR measurements from 1054 patients were analyzed. UICR was significantly higher in case of rhTSH use than THW (72.4 ± 48.1 vs. 29.9 ± 45.8 μg/g Cr, P < 0.001). In patients who underwent LID twice using both TSH stimulation protocols alternately, UICR was higher in case of rhTSH than THW regardless of the order of method. Among clinical factors, female, old-age, and the first LID were significant factors to show higher UICR. Although the adequacy of LID was 'adequate' or 'excellent' in most patients, multivariate analysis demonstrated that THW method, male, young age, and prior LID-experience were significant determinants for achieving 'excellent' adequacy of LID. In conclusion, UICR was higher and the proportion of 'excellent' LID adequacy was lower with rhTSH than with THW. UICR was higher also in women, old-age, and LID-naïve patients. Further researches are required to suggest effective methods to reduce body iodine pool in case of rhTSH use and to validate the efficacy of such methods on outcomes of RAI treatment.Affiliations
Hwanhee Lee 1 2, Jin Chul Paeng 1, Hongyoon Choi 1, Sun Wook Cho 3, Young Joo Park 3, Do Joon Park 3, Young Ah Lee 4, June-Key Chung 1, Keon Wook Kang 1, Gi Jeong Cheon 1
1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
2Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
4Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea.
- 덧글달기
편집위원
갑상선암의 방사성요오드치료에 필수적인 저요드식이가 TSH 를 놓이는 방법에 따라 영향이 있는지를 보여준 임상연구임. 갑상선호르몬투여중리를 이용한 환자에서 저요드식이의 결과가 더 좋게 나타남을 보여주였고, 남자와 젊은 환자에서 저요드식이의 효과가 높다는 것을 보여준 임상연구로 핵의학임상가 및 갑상선암의 방사성요오드 치료에 관심이 있는 내분비내과 의사에게 관심을 끌 연구로 생각됨.
덧글달기닫기2021-10-19 14:47:58
등록